Advertisement

Topics

Vena Cava Filter U.S. Clinical Trial

2014-07-23 21:09:24 | BioPortfolio

Summary

The investigation is designed to verify that clinical use of the vena cava filter does not raise new questions of safety or effectiveness compared to currently-marketed permanent filters.

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Conditions

Pulmonary Embolism

Intervention

VenaTech Convertible Vena Cava Filter, Vena Cava Filter Conversion

Location

Northwestern Memorial Hospital
Chicago
Illinois
United States
60611

Status

Not yet recruiting

Source

B. Braun Interventional Systems, Inc

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-07-23T21:09:24-0400

Clinical Trials [193 Associated Clinical Trials listed on BioPortfolio]

Cook IVC Filter Study

This prospective, multicenter, single-arm clinical study will further evaluate the safety and effectiveness of Cook's permanent and retrievable inferior vena cava (IVC) filters (specifical...

Study of IVC Filter Retrieval With the Günther Tulip Vena Cava Filter

The purpose of this study is to test the hypothesis that the Günther Tulip Vena Cava Filter can be removed after a period of implantation, when implanted in patients for the prevention of...

Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter 4

The purpose of this study is to determine if the Crux Vena Cava Filter System is safe and effective in preventing pulmonary embolism.

A Safety and Efficacy Study for Implantation and Retrieval Procedures Using the VENATECH® Retrieval Filter System

To establish the clinical safety and efficacy of the VenaTech® Retrievable Vena Cava Filter

Crux Biomedical IVC Filter - Evaluation of the Crux Inferior Vena Cava Filter System (Retrieve)

This is an open label, non-randomized, prospective, multicenter study.

PubMed Articles [718 Associated PubMed Articles listed on BioPortfolio]

Femoral versus jugular access for Denali Vena Cava Filter placement: Analysis of fluoroscopic time, filter tilt and retrieval outcomes.

To analyze relevant metrics involved in Denali Vena Cava Filter placement via different venous access sites.

The first reported case of factor V Leiden mutation with agenesis of superior vena cava: A case report.

Total absence of superior vena cava (ASVC) is a very rare anomaly, and the patient usually suffers from superior vena cava syndrome (SVCS) or conduction disturbances.

A Review of Interventions to Increase Vena Cava Filter Retrieval Rates.

Inferior vena cava filters (IVCFs) are indicated for therapeutic and prophylactic treatment of venous thromboembolism in patients where anti-coagulation has failed or is contraindicated. Retrievable I...

Successful Catheter Treatment Using Pre-Operative 3D Organ Model Simulation for Atrial Septal Defect With Dextrocardia and Interrupted Inferior Vena Cava to the Superior Vena Cava.

Embolization of Struts from an Inferior Vena Cava Filter.

Medical and Biotech [MESH] Definitions

Mechanical devices inserted in the inferior vena cava that prevent the migration of blood clots from deep venous thrombosis of the leg.

A vein which arises from the right ascending lumbar vein or the vena cava, enters the thorax through the aortic orifice in the diaphragm, and terminates in the superior vena cava.

A condition that occurs when the obstruction of the thin-walled SUPERIOR VENA CAVA interrupts blood flow from the head, upper extremities, and thorax to the RIGHT ATRIUM. Obstruction can be caused by NEOPLASMS; THROMBOSIS; ANEURYSM; or external compression. The syndrome is characterized by swelling and/or CYANOSIS of the face, neck, and upper arms.

An operation for the continuous emptying of ascitic fluid into the venous system. Fluid removal is based on intraperitoneal and intrathoracic superior vena cava pressure differentials and is performed via a pressure-sensitive one-way valve connected to a tube traversing the subcutaneous tissue of the chest wall to the neck where it enters the internal jugular vein and terminates in the superior vena cava. It is used in the treatment of intractable ascites.

The small mass of modified cardiac muscle fibers located at the junction of the superior vena cava (VENA CAVA, SUPERIOR) and right atrium. Contraction impulses probably start in this node, spread over the atrium (HEART ATRIUM) and are then transmitted by the atrioventricular bundle (BUNDLE OF HIS) to the ventricle (HEART VENTRICLE).

More From BioPortfolio on "Vena Cava Filter U.S. Clinical Trial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial